VistaGen Therapeutics, Inc. Soared

Mon, Dec 16, 2019 at 05:30 PM
VistaGen Therapeutics, Inc. Soared

VistaGen Therapeutics, Inc. (VTGN:NASDAQ) jumped higher at $1.01, representing a gain of 44.3%. On Fri 13 Dec 19, VTGN:NASDAQ touched a New 2-Week High of $0.7. The stock got featured on our News Catalysts scanner on Wed 11 Dec 19 at 12:09 PM in the 'BIOTECH' category. From Fri 22 Nov 19, the stock recorded 57.14% Up Days and 46.67% Green Days

About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)

VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.